There was a statistically significant difference found in serum urotensin II levels as the OSA group had a higher serum level compared to the control group (3.41 ± 1.72 vs. 2.18 ± 1.36 ng/mL; p < 0.001) (Figure 1). This evidence concerns the gene UTS2 and obstructive sleep apnea syndrome.